After WHO nod for Covaxin, India in touch with more countries for approval: Report
The global health body granted emergency use listing to the Bharat Biotech developed jab on November 3.
The Ministry of external affairs (MEA) has reached out to a number of countries to secure approval for Covaxin, India’s first indigenous vaccine against the coronavirus disease (Covid-19), following emergency use listing (EUL) from the World Health Organization (WHO), which the jab received on November 3. While the MEA is holding discussions with counterparts from various countries over the issue, India’s diplomatic missions, too, are in talks with their respective host nations in this regard.
“After EUL from the global health body, efforts to get Covaxin recognised have been ramped up. The number of world governments to recognise the vaccine is likely to rise following WHO’s nod,” Hindustan Times’ sister publication Livehindustan reported, citing a media report.
At present, several countries allow fully vaccinated Indian nationals to enter without mandatory quarantine upon arrival. However, majority of these have recognised Covishield, the Indian variant of Britain’s AstraZeneca jab. Covaxin, on the other hand, has been approved by nearly a dozen nations. From November 8, the United States, too, will allow entry to travellers jabbed with the made-in-India vaccine.